Department of Neurosurgery.
Neurosurg Focus. 2014 Feb;36(2):E11. doi: 10.3171/2013.12.FOCUS13485.
Subtotal resection (STR) of spinal tumors can result in tumor recurrence. Currently, no clinically reliable marker is available for intraoperative visualization of spinal tumor tissue. Protoporphyrin IX (PpIX) fluorescence induced by 5-aminolevulinic acid (5-ALA) is capable of visualizing malignant gliomas. Fluorescence-guided resections of malignant cerebral gliomas using 5-ALA have resulted in an increased rate of complete tumor removal. Recently, the application of 5-ALA has also been described in the first cases of spinal tumors. Therefore, the aim of this observational study was to systematically investigate 5-ALA-induced fluorescence characteristics in different spinal tumor entities.
Three hours before the induction of anesthesia, 5-ALA was administered to patients with different intra- and extradural spinal tumors. In all patients a neurosurgical resection or biopsy of the spinal tumor was performed under conventional white-light microscopy. During each surgery, the presence of PpIX fluorescence was additionally assessed using a modified neurosurgical microscope. At the end of an assumed gross-total resection (GTR) under white-light microscopy, a final inspection of the surgical cavity of fluorescing intramedullary tumors was performed to look for any remaining fluorescing foci. Histopathological tumor diagnosis was established according to the current WHO classification.
Fifty-two patients with 55 spinal tumors were included in this study. Resection was performed in 50 of 55 cases, whereas 5 of 55 cases underwent biopsy. Gross-total resection was achieved in 37 cases, STR in 5, and partial resection in 8 cases. Protoporphyrin IX fluorescence was visible in 30 (55%) of 55 cases, but not in 25 (45%) of 55 cases. Positive PpIX fluorescence was mainly detected in ependymomas (12 of 12), meningiomas (12 of 12), hemangiopericytomas (3 of 3), and in drop metastases of primary CNS tumors (2 of 2). In contrast, none of the neurinomas (8 of 8), carcinoma metastases (5 of 5), and primary spinal gliomas (3 of 3; 1 pilocytic astrocytoma, 1 WHO Grade II astrocytoma, 1 WHO Grade III anaplastic oligoastrocytoma) revealed PpIX fluorescence. It is notable that residual fluorescing tumor foci were detected and subsequently resected in 4 of 8 intramedullary ependymomas despite assumed GTR under white-light microscopy.
In this study, 5-ALA-PpIX fluorescence was observed in spinal tumors, especially ependymomas, meningiomas, hemangiopericytomas, and drop metastases of primary CNS tumors. In cases of intramedullary tumors, 5-ALA-induced PpIX fluorescence is a useful tool for the detection of potential residual tumor foci.
脊柱肿瘤的次全切除术(STR)可导致肿瘤复发。目前,术中可视化脊柱肿瘤组织尚无临床可靠的标志物。5-氨基酮戊酸(5-ALA)诱导的原卟啉 IX(PpIX)荧光能够可视化恶性胶质瘤。使用 5-ALA 对恶性脑胶质瘤进行荧光引导切除已导致完全肿瘤切除率提高。最近,5-ALA 的应用也已在首例脊柱肿瘤中得到描述。因此,本观察性研究的目的是系统地研究不同脊柱肿瘤实体中 5-ALA 诱导的荧光特征。
在麻醉诱导前 3 小时,向患有不同硬膜内和硬膜外脊柱肿瘤的患者给予 5-ALA。所有患者均在常规白光显微镜下进行脊柱肿瘤的神经外科切除术或活检。在每次手术中,还使用改良的神经外科显微镜评估 PpIX 荧光的存在。在白光显微镜下假设进行大体全切除(GTR)后,对荧光髓内肿瘤的手术腔进行最终检查,以寻找任何残留的荧光焦点。根据当前的 WHO 分类建立肿瘤的组织病理学诊断。
本研究纳入了 52 例 55 个脊柱肿瘤患者。55 例中有 50 例进行了切除,5 例进行了活检。在 37 例中实现了大体全切除,STR 在 5 例中,部分切除在 8 例中。30 例(55%)可见 PpIX 荧光,但 25 例(45%)不可见。PpIX 荧光主要在室管膜瘤(12 例中的 12 例)、脑膜瘤(12 例中的 12 例)、血管外皮细胞瘤(3 例中的 3 例)和中枢神经系统原发性肿瘤的转移瘤(2 例中的 2 例)中检测到。相比之下,神经瘤(8 例中的 8 例)、癌转移瘤(5 例中的 5 例)和原发性脊柱神经胶质瘤(3 例中的 3 例;1 例毛细胞星形细胞瘤、1 例 WHO 分级 II 星形细胞瘤、1 例 WHO 分级 III 间变性少突星形细胞瘤)均未显示 PpIX 荧光。值得注意的是,尽管在白光显微镜下假设进行了 GTR,但在 4 例髓内室管膜瘤中仍检测到并随后切除了残留的荧光肿瘤焦点。
在本研究中,5-ALA-PpIX 荧光在脊柱肿瘤中观察到,尤其是室管膜瘤、脑膜瘤、血管外皮细胞瘤和中枢神经系统原发性肿瘤的转移瘤。对于髓内肿瘤,5-ALA 诱导的 PpIX 荧光是检测潜在残留肿瘤焦点的有用工具。